Raymond James Financial Services Advisors, Inc. Aurinia Pharmaceuticals Inc. Call Options Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

Call Options

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2018 Nov 14, 2018	SELL	$5.27 - $6.64 $98,021 - $123,504	-18,600 Closed	0 $0
Q2 2018 Jul 30, 2018	SELL	$5.06 - $6.36 $79,948 - $100,488	-15,800 Reduced 45.93%	18,600 $7,000
Q2 2017 Aug 15, 2017	BUY	N/A	34,400	34,400 $3,000

Others Institutions Holding AUPH

# of Institutions

239

Shares Held

64.9M

Call Options Held

1.1M

Put Options Held

772K

Tang Capital Management LLC San Diego, CA

10M
Shares

$81.1 Million
5.24% of portfolio
Black Rock Inc. New York, NY

9.27M
Shares

$75 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5M
Shares

$40.5 Million
0.61% of portfolio
Nea Management Company, LLC Timonium, MD

3.97M
Shares

$32.1 Million
3.03% of portfolio
State Street Corp Boston, MA

2.85M
Shares

$23.1 Million
0.0% of portfolio

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.15B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account